Nikkei 225 Hits Record High Above 56,000 After Japan Election Boosts Market Confidence 
Yen Slides as Japan Election Boosts Fiscal Stimulus Expectations 
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
Lee Seung-heon Signals Caution on Rate Hikes, Supports Higher Property Taxes to Cool Korea’s Housing Market 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility 
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible 
Samsung Electronics Shares Jump on HBM4 Mass Production Report 
Gold and Silver Prices Climb in Asian Trade as Markets Eye Key U.S. Economic Data 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Abbott, medical devices and health care company headquartered in Abbott Park, Illinois, has issued a recall for three of its leading baby formulas, including Similac, Alimentum, and EleCare. The recall was due to the discovery of cases where infants fell ill after consuming the milk brands.
According to Fox Business, the cases involve four infants in three states - Ohio, Texas, and Minnesota. The U.S. Food and Drug Administration stated that the powdered milk for infants was manufactured in Abbott Nutrition's Sturgis, Michigan facility.
The FDA is investigating the four cases that caused Cronobacter sakazakii and Salmonella Newport infections in the said regions. The babies were said to have been hospitalized, and there was one case of death where the FDA suspects that the Cronobacter may have contributed to the unfortunate incident.
In its recall announcement, the agency, along with U.S. Centers for Disease Control and Prevention, have warned and advised the public to refrain from buying certain Abbott powdered baby formulas that were made at the Sturgis, Michigan plant. It also mentioned that the investigation is still ongoing.
Moreover, the FDA is informing everyone to discard Similac, Alimentum, and EleCare baby milk formulas if the first two digits of the code are 22 to 37 and if the code on the container shows K8, SH, or Z2. The expiration date of the affected milk is April 1, 2022, or later.
At any rate, Abbott voluntarily recalled the affected products after receiving four complaints from the consumers. Then again, the company stressed that the recall is an isolated case and only affects powder formulas - Similac, Alimentum, and EleCare - that were made at its Sturgis, Michigan plant. The company further said that the liquid formulas or other Abbott nutrition powders are not included in the recall.
"We know parents depend on us to provide them with the highest quality nutrition formulas," Abbott's executive vice president, nutritional products, Joe Manning, said in a press release. "We are taking this action so parents know they can trust us to meet our high standards, as well as theirs. We deeply regret the concern and inconvenience this situation will cause parents, caregivers, and health care professionals."
Finally, the FDA Deputy Commissioner for Food Policy and Response, Frank Yiannas, said they are working to solve the safety concerns as soon as possible as they are aware of the severity of the issue.
